Erythromycin | CAS 114-07-8 | USP/EP Grade | Ausamics
$0.00 AUD
Erythromycin Powder
AuSaMicS Life Science™ | www.ausamics.com.au
Product Description
Cat. No. ASA-2010
For Laboratory Use Only
Catalog Number
ASA-2010
CAS Number
114-07-8
Molecular Weight
733.93 g/mol
Molecular Formula
C37H67NO13
Compound Class
Macrolide Antibiotic
Form
Powder
Description
Erythromycin Powder is a powerful macrolide antibiotic used in microbiology and laboratory research. It exhibits broad-spectrum antibacterial activity against a range of sensitive organisms and is widely used in controlled research, antimicrobial investigations, and microbiological testing workflows.
Its mechanism of action involves inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, specifically the 23S ribosomal RNA of susceptible bacteria. This interaction disrupts the peptidyl transferase center, which is essential for peptide bond formation during protein translation, thereby inhibiting bacterial growth.
Erythromycin is effective against many Gram-positive bacteria, including Streptococcus pneumoniae, Enterococcus faecalis, and Staphylococcus aureus. It also shows activity against selected Gram-negative bacteria such as Neisseria gonorrhoeae, Bordetella pertussis, and Legionella pneumophila, as well as atypical organisms including Chlamydia trachomatis and Mycoplasma pneumoniae.
Key Features & Benefits
🧫
Broad-Spectrum Activity
Active against a range of Gram-positive, selected Gram-negative, and atypical bacteria in laboratory settings.
🧬
Protein Synthesis Inhibitor
Binds to the 50S ribosomal subunit and disrupts peptide bond formation during translation.
🔬
Microbiology Research Utility
Suitable for antimicrobial studies, susceptibility investigations, and controlled laboratory work.
🦠
Atypical Organism Coverage
Useful in research involving organisms such as Chlamydia trachomatis and Mycoplasma pneumoniae.
Typical Laboratory Applications
🧪
Microbiology Research
- Studies of antibacterial activity and resistance
- Research involving Gram-positive and selected Gram-negative bacteria
- Protein synthesis inhibition investigations
📊
Analytical & Comparative Studies
- Macrolide antibiotic comparison studies
- Reference material for laboratory testing workflows
- Research involving atypical bacterial pathogens
Product Specifications
Product NameErythromycin Powder
Catalog NumberASA-2010
CAS Number114-07-8
Molecular Weight733.93 g/mol
Molecular FormulaC37H67NO13
Compound ClassMacrolide antibiotic
MechanismInhibits bacterial protein synthesis by binding to the 50S ribosomal subunit and 23S rRNA
Target ProfileActive against many Gram-positive bacteria, selected Gram-negative bacteria, and atypical organisms
Handling & Storage
HandlingHandle using standard laboratory safety procedures and avoid unnecessary exposure to dust.
StorageStore in a tightly sealed container under recommended laboratory storage conditions.
Use LimitationFor laboratory use only.
⚠ Warning
For Laboratory Use Only. Not intended for human, animal, food, diagnostic, or therapeutic use.
Disclaimer
This product is supplied for laboratory and research use only. End users are responsible for verifying suitability for their intended application and for handling the material in accordance with applicable laboratory, safety, and regulatory requirements.
Safety Data Sheet
Erythromycin Powder | Cat. ASA-2010
SDS — GHS Format
SDS-ASA-2010 | Rev. 1.0
Issue Date: March 2026
Section 1 — Identification
Product NameErythromycin Powder
Catalog No.ASA-2010
CAS Number114-07-8
Recommended UseLaboratory research and microbiology use only
SupplierAuSaMicS Pty Ltd, 31 Longview CT, Thomastown VIC 3074, Australia
Emergency Contact+61 412 520 598 | support@ausamics.com.au
Emergency ServicesAustralia: 000 | Poisons Information Centre: 13 11 26
Section 2 — Hazard Identification
GHS Classification: Handle as a laboratory chemical. Avoid inhalation of dust and contact with eyes, skin, and clothing. Use only by trained personnel following suitable laboratory procedures.
Signal WordUse with caution
Hazard StatementsMay cause irritation if inhaled or if it comes into contact with eyes or skin. Avoid generating dust.
Precautionary StatementsUse good laboratory practice. Wear suitable gloves, eye protection, and laboratory coat when handling.
Regulatory StatusFor laboratory use only. Not intended for human, animal, food, diagnostic, or therapeutic use.
Section 3 — Composition / Ingredients
| Component | Specification | Function / Notes |
|---|---|---|
| Erythromycin | Main component | Macrolide antibiotic |
| CAS Number | 114-07-8 | Chemical identifier |
| Molecular Formula | C37H67NO13 | Reference formula |
| Molecular Weight | 733.93 g/mol | Reference molecular weight |
Section 4 — First Aid Measures
Skin ContactWash thoroughly with soap and water. Seek medical advice if irritation develops.
Eye ContactRinse cautiously with water for several minutes. Seek medical advice if irritation persists.
InhalationMove to fresh air. Seek medical advice if symptoms occur.
IngestionRinse mouth with water. Seek medical advice if discomfort occurs.
Section 5 — Fire-Fighting Measures
Suitable Extinguishing MediaWater spray, foam, dry chemical, or carbon dioxide
Specific HazardsThermal decomposition may generate irritating fumes and combustion products
Protective EquipmentUse standard fire-fighting PPE and respiratory protection where required
Section 6 — Accidental Release Measures
Personal PrecautionsAvoid dust generation and wear suitable PPE during cleanup.
Environmental PrecautionsPrevent bulk release to drains and waterways.
Clean-Up MethodsCarefully sweep or collect material into a suitable container. Clean remaining residue with damp disposable material.
Sections 7–16 — Handling, Storage, PPE, Physical, Stability, Disposal, Transport, Regulatory
HandlingUse standard laboratory practices. Avoid inhalation of dust and direct contact with eyes or skin.
StorageStore in a tightly sealed container under recommended laboratory storage conditions.
PPEGloves, safety glasses, and laboratory coat recommended.
AppearancePowder
Molecular Weight733.93 g/mol
Molecular FormulaC37H67NO13
StabilityStable under recommended laboratory storage conditions
DisposalDispose according to local laboratory and environmental regulations
TransportHandle and ship in accordance with applicable regulations
Prepared ByAuSaMicS Pty Ltd — Quality & Regulatory Affairs
Disclaimer
This SDS-style content is provided in website format and should be aligned with your approved internal or regulatory safety documentation before publication where required.
Certificate of Analysis
Erythromycin Powder | Cat. ASA-2010
COA — Batch Specific
COA-ASA-2010-L001
Issue Date: March 2026
Product Information
Product NameErythromycin Powder
Catalog No.ASA-2010
CAS Number114-07-8
Molecular Weight733.93 g/mol
Molecular FormulaC37H67NO13
Compound ClassMacrolide antibiotic
Lot / Batch Information
Lot NumberASA2010-L001
Manufacture DateMarch 2026
Expiry / Retest DateMarch 2029
AppearanceConforms ✓
Pack SizeTBD
StorageStore tightly sealed under recommended laboratory conditions
Analytical Test Results
| No. | Test / Criteria | Method | Specification / Limit | Result | Status |
|---|---|---|---|---|---|
| 1 | Appearance | Visual inspection | Conforms to standard powder appearance | Conforms | PASS |
| 2 | Identification | Reference / approved method | Conforms to product identity | Conforms | PASS |
| 3 | Molecular Weight Reference | Specification review | 733.93 g/mol | Conforms | PASS |
| 4 | Molecular Formula Reference | Specification review | C37H67NO13 | Conforms | PASS |
| 5 | Handling Quality | Internal QC | Conforms to internal specification | Conforms | PASS |
Overall Batch Disposition
RELEASED — COMPLIES WITH SPECIFICATIONS
Authorisation
Analysed By
QC Analyst | AuSaMicS Pty Ltd
Date: _______________
Approved & Released By
Quality Manager | AuSaMicS Pty Ltd
Date: _______________
Disclaimer
This Certificate of Analysis applies only to the batch identified above and reflects testing of a representative sample. End users should verify suitability under their own operating conditions and quality systems.